Brain Scans Reveal Two Distinct Physical Subtypes of ADHD

Why It Matters

Identifying biologically distinct ADHD subtypes could enable precision‑medicine approaches, improving treatment efficacy and reducing trial‑and‑error prescribing. This shift may also refine diagnostic criteria and guide future neurodevelopmental research.

Key Takeaways

• Machine learning identified two ADHD brain subtypes.
• Subtype A shows frontal and cerebellar gray matter increase.
• Subtype B exhibits widespread gray matter loss, especially hippocampus.
• Inattention dominates subtype A; hyperactivity/impulsivity dominate subtype B.
• Findings suggest future precision‑medicine ADHD diagnostics.

Pulse Analysis

Attention‑deficit/hyperactivity disorder has long puzzled clinicians because its outward symptoms vary dramatically from one patient to another. Traditional diagnostic categories rely on behavioral checklists, yet neuroimaging studies have produced inconsistent findings, often obscuring underlying biology. By applying advanced clustering algorithms to high‑resolution structural MRI data, researchers have begun to peel back this heterogeneity, revealing that ADHD is not a monolithic brain disorder but rather comprises distinct anatomical phenotypes. This paradigm shift aligns with broader trends in psychiatry toward data‑driven subtyping, offering a clearer bridge between brain structure and clinical presentation.

The Chinese research team analyzed scans from 135 diagnosed youths and 182 neurotypical controls, first confirming that pooled analyses mask significant differences. Their machine‑learning model separated the cohort into two groups: one with enlarged gray‑matter volumes in frontal cortices and the cerebellum, and another with pronounced atrophy in the same frontal areas, cerebellum, and hippocampus. Behavioral profiling showed the first group suffered mainly from inattentiveness, whereas the second displayed a blend of inattention, hyperactivity, and impulsivity. A pseudo‑time series linked these anatomical patterns to symptom severity, identifying frontal‑cerebellar hubs for the inattentive subtype and a broader network—including the hippocampus—for the more severe, hyperactive subtype.

If replicated in longitudinal cohorts, these findings could transform ADHD care. Clinicians might soon order a single MRI to assign a patient to a neuroanatomical subtype, then tailor interventions—cognitive training for the attention‑focused group and combined pharmacologic‑behavioral regimens for the atrophy‑dominant group. Moreover, pharmaceutical development could target the specific neural circuits implicated in each subtype, accelerating the move toward precision psychiatry. Continued investment in multi‑site imaging consortia and long‑term follow‑up will be essential to validate these subtypes and integrate them into routine practice.